Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.
about
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancerSALL4, the missing link between stem cells, development and cancerComparison of hepatocellular carcinoma in Eastern versus Western populations.Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis.Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma.SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma.Positive immunostaining of Sal-like protein 4 is associated with poor patient survival outcome in the large and undifferentiated Korean hepatocellular carcinoma.Oncogenic protein SALL4 and ZNF217 as prognostic indicators in solid cancers: a meta‑analysis of individual studiesMicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4Functional and clinical significance of SALL4 in breast cancer.Hepatocellular Malignant Neoplasm-NOS: A Clinicopathologic Study of 11 Cases from a Single Institution.The diagnostic and prognostic value of SALL4 in hepatoblastoma.Anticancer Properties of Chrysin on Colon Cancer Cells, In vitro and In vivo with Modulation of Caspase-3, -9, Bax and Sall4.MicroRNA-219 exerts a tumor suppressive role in glioma via targeting Sal-like protein 4.Methylation-induced downregulation and tumor-suppressive role of microRNA-98 in glioma through targeting Sal-like protein 4.Higher expression of SALL4 predicts poor cancer prognosis: A meta-analysis.Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy.Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide
P2860
Q26746010-D33C567B-3C68-48AB-A52D-AF63B705952EQ28273464-15E13DDF-5727-4195-B7A3-5BDB9E1080E5Q30245396-1CF049A3-518D-4DA7-ABB4-576B73932A96Q33618541-0F7094B0-9A5B-4E55-829F-9014612826D3Q35661679-2D98FCAD-1424-467B-AECA-F7BA5C232A25Q36413790-3FB0AD09-8375-4C6E-9D52-CD7F7D14A903Q37088921-96483AEE-010D-40A7-96FD-7CE135156504Q37269289-59DF479B-D08B-4B6D-A594-FBD2EDE09B47Q37687523-D581966E-98D9-438B-9BFB-4708B0AE3F4AQ38805786-8470A4BE-2AA3-4D2F-BC4B-BAC45CD30BB8Q39404128-2C1E2EA8-83A5-4E32-90BC-44C34FAAF754Q40723827-D465772F-12B8-41D7-8F42-06703B32F155Q41674134-D9D5D616-61CC-4FB3-8906-7289060A1C10Q47094148-4DC78AA0-209B-4DEC-AD45-0013D9FD5CF9Q50045047-0F8A436F-FA1A-48E8-BDE4-AC7B96D8BA27Q50958719-5AFD094B-3B41-453C-888A-F407F52DDA07Q52648392-542FBCBC-F726-48CB-B1F3-BCBA442FC9EAQ53106095-76917BAC-467B-47ED-8EED-393EAEFD6AF1Q57956038-6644AAAC-911D-4ACB-8078-5D7F77FAB70B
P2860
Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Serum SALL4 is a novel prognos ...... s in hepatocellular carcinoma.
@ast
Serum SALL4 is a novel prognos ...... s in hepatocellular carcinoma.
@en
type
label
Serum SALL4 is a novel prognos ...... s in hepatocellular carcinoma.
@ast
Serum SALL4 is a novel prognos ...... s in hepatocellular carcinoma.
@en
prefLabel
Serum SALL4 is a novel prognos ...... s in hepatocellular carcinoma.
@ast
Serum SALL4 is a novel prognos ...... s in hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Serum SALL4 is a novel prognos ...... ts in hepatocellular carcinoma
@en
P2093
Chen-chen He
Jun-lan Wang
Xi-jing Guo
Yuan-yuan Zhang
P2860
P304
P356
10.1155/2014/262385
P50
P577
2014-04-17T00:00:00Z